CHRNB2 Antibody - middle region

Artikelnummer: ASB-ARP34970_T100
Artikelname: CHRNB2 Antibody - middle region
Artikelnummer: ASB-ARP34970_T100
Hersteller Artikelnummer: ARP34970_T100
Alternativnummer: ASB-ARP34970_T100-25UL,ASB-ARP34970_T100-100UL
Hersteller: Aviva
Wirt: Rabbit
Kategorie: Proteine/Peptide
Applikation: IHC, WB
Spezies Reaktivität: Bovine, Canine, Guinea pig, Human, Mouse, Porcine, Rat
Immunogen: The immunogen is a synthetic peptide directed towards the middle region of human CHRNB2
Alternative Synonym: EFNL3, nAChRB2
Mutations in nAChRs are found in a rare form of nocturnal frontal lobe epilepsy . Previously, some nAChR mutations have been described that are associated with additional neurological features such as psychiatric disorders or cognitive defects. A new CHRNB2 mutation located in transmembrane region 3 (M3), outside the known ADNFLE mutation cluster. The CHRNB2 mutation I312M, which occurred de novo in twins, markedly increases the receptors sensitivity to acetylcholine. Phenotypically, the mutation is associated not only with typical ADNFLE, but also with distinct deficits in memory. The cognitive problems are most obvious in tasks requiring the organization and storage of verbal information.
Klonalität: Polyclonal
Konzentration: 1.0 mg/ml
Molekulargewicht: 57kDa
NCBI: 1141
UniProt: P17787
Formulierung: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Human kidney
WB Suggested Anti-CHRNB2 Antibody Titration: 2.5ug/ml
Positive Control: Jurkat cell lysateCHRNB2 is supported by BioGPS gene expression data to be expressed in Jurkat
CHRNB2 antibody - middle region (ARP34970_T100) in Human Jurkat using Western Blot